Omaha, Nebraska

Velocity Clinical Research, Omaha

Velocity's research site in Omaha frequently conducts clinical trials for a broad range of investigational treatments under the leadership of Velocity's Chief Physician Officer and principal investigator Brandon J. Essink, MD. Typical studies at this site involve medications for acne, allergies, chronic diseases, depression, high cholesterol, diabetes, infectious diseases, and other conditions. This site also performs vaccine studies for people of all ages. Acquired by Velocity in 2022, the Omaha location was founded in 1999 as the first site and main headquarters for Meridian Clinical Research.

Located just off I-680 in Omaha, near the Northeast corner of 108th and Maple, this location provides services in two buildings and is easily accessible to thousands of patients. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Omaha team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Velocity Clinical Research, Omaha
3319 N. 107th St., Omaha, NE 68134

Phone: (402) 933-6500

Email: info@velocityclinical.com

Find a Clinical Trial in Omaha
Use the dropdown to browse current studies in Omaha.

Follow Velocity on Facebook for company updates and more.

Portrait Of Medical Team Standing Outside Hospital

About Velocity Clinical Research

155,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Our experienced research team in Omaha

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Omaha is dedicated to conducting quality research in a professional and caring environment.

  • Brandon J. Essink, MD, CPI

    Chief Physician Officer, Principal Investigator
    Brandon Essink, MD, CPI has served as a principal investigator since 2003 and is Velocity’s Chief Physician Officer. In his role, Dr. Essink directs clinical practice operations at Velocity’s dedicated research center in Omaha, NE. He is frequently selected to lead pioneering vaccine research programs because of his extensive experience in the field and the superb track record sites have maintained under his guidance. Board certified in Family Practice, Dr. Essink received his medical degree from University of Nebraska Medical Center in Omaha, NE. He completed his residency in family practice at University of Nebraska Medical Center and a family practice fellowship at University of Nebraska Medical Center.

  • Fritz Raiser, DO

    Principal Investigator
    Fritz Raiser, DO specializes in Emergency Medicine, and is affiliated with Methodist Hospital. Board certified in Emergency Medicine, Dr. Raiser received his medical degree from Lake Erie College of Osteopathic Medicine and completed his residency at Doctor’s Hospital in Columbus, OH.

  • Alan Wilson, MD

    Principal Investigator

Learn More About Participating in a Clinical Trial

The latest in fatty liver disease and NASH research

The Latest in Steatotic Liver Disease and MASH Research: Promising Advances in Treatment

What are MASH and Steatotic Liver Disease?  Steatotic liver disease (formerly known as fatty liver disease) is a condition characterized by the accumulation of fat in the liver. It can … Read more

What is Informed Consent

What is Informed Consent?

Joining a clinical trial is an important decision. Most participants come to the clinic with questions about clinical trials and what joining one could mean. This is why every study … Read more

Clinical Trial Phases What Happens in Phase 1, 2, 3 and 4

Clinical Trial Phases: What Happens in Phase 1, 2, 3 and 4?

Clinical trials are research studies of medications, vaccines, medical devices, procedures, diagnostics (tests), and other health-related products. These studies involve participants (also known as patients, volunteers, or subjects) to determine … Read more

Maryann - research study participant testimonial

Participant Story: Maryann, a Research Study Participant at Velocity

What led you to participate in a research study? I saw a roadside poster near the university in my neighborhood [for a vaccine study] and called Velocity. My first experience … Read more

Complete the form to start your clinical trial journey in Omaha

Why join a clinical trial?

  • Help advance medicine
  • Learn about potential new medicines in development
  • Get study-related medical exams at no cost
  • Receive compensation for participating (available amounts may differ for each study)

After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.

Health insurance is generally not needed to join a clinical trial.

Remember, there is never an obligation to join — we're here to help you make the best decision.

Submit your info

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.